tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Chemed reiterates FY25 EPS guidance of $22.00-$22,30, consensus $22.15

This guidance assumes that there will be no Medicare Cap related to the company’s Florida combined program for the government FY26 beginning on October 1, 2025.

TipRanks Cyber Monday Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1